Literature DB >> 23949438

[PET/MRI for cardiac imaging. Possibilities and limits].

C Rischpler1, S G Nekolla.   

Abstract

CLINICAL/METHODICAL ISSUE: The positron emission tomography/magnetic resonance imaging (PET/MRI) technique represents a new hybrid imaging modality in nuclear cardiology. STANDARD RADIOLOGICAL
METHODS: The standard radiological method in this field is PET/computed tomography (CT). METHODICAL INNOVATIONS: For morphological correlation MRI is used instead of CT. Furthermore, the creation of attenuation maps (μ-maps) has to be accomplished using MRI data. PERFORMANCE: For this new hybrid imaging modality only limited data are so far available, especially in the field of nuclear cardiology; however, the available data show a relatively good agreement between both modalities with the PET/CT as the modality of reference. ACHIEVEMENTS: In comparison to PET/CT a major advantage of PET/MRI is the lower radiation dose to the patient; however, the more complex workflow using this new imaging modality also has to be taken into account. Furthermore, some indications are still at an experimental stage using the PET/MRI. PRACTICAL RECOMMENDATIONS: In daily practice, PET/MRI should be considered especially in younger patients due to the lower exposure to radiation. Furthermore, there are some advantages for this modality in the field of nuclear cardiology, such as imaging of inflammatory myocardial processes (e.g. cardiac sarcoidosis) or myocardial viability imaging.

Entities:  

Mesh:

Year:  2013        PMID: 23949438     DOI: 10.1007/s00117-013-2498-1

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  35 in total

1.  ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging).

Authors:  Francis J Klocke; Michael G Baird; Beverly H Lorell; Timothy M Bateman; Joseph V Messer; Daniel S Berman; Patrick T O'Gara; Blase A Carabello; Richard O Russell; Manuel D Cerqueira; Martin G St John Sutton; Anthony N DeMaria; James E Udelson; J Ward Kennedy; Mario S Verani; Kim Allan Williams; Elliott M Antman; Sidney C Smith; Joseph S Alpert; Gabriel Gregoratos; Jeffrey L Anderson; Loren F Hiratzka; David P Faxon; Sharon Ann Hunt; Valentin Fuster; Alice K Jacobs; Raymond J Gibbons; Richard O Russell
Journal:  J Am Coll Cardiol       Date:  2003-10-01       Impact factor: 24.094

2.  Automatic, three-segment, MR-based attenuation correction for whole-body PET/MR data.

Authors:  V Schulz; I Torres-Espallardo; S Renisch; Z Hu; N Ojha; P Börnert; M Perkuhn; T Niendorf; W M Schäfer; H Brockmann; T Krohn; A Buhl; R W Günther; F M Mottaghy; G A Krombach
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-10-05       Impact factor: 9.236

3.  Impact of myocardial perfusion imaging with PET and (82)Rb on downstream invasive procedure utilization, costs, and outcomes in coronary disease management.

Authors:  Michael E Merhige; William J Breen; Victoria Shelton; Teresa Houston; Brian J D'Arcy; Anthony F Perna
Journal:  J Nucl Med       Date:  2007-07       Impact factor: 10.057

Review 4.  PET and MRI in cardiac imaging: from validation studies to integrated applications.

Authors:  Stephan G Nekolla; Axel Martinez-Moeller; Antti Saraste
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03       Impact factor: 9.236

5.  In vivo molecular imaging of angiogenesis, targeting alphavbeta3 integrin expression, in a patient after acute myocardial infarction.

Authors:  Marcus R Makowski; Ullrich Ebersberger; Stephan Nekolla; Markus Schwaiger
Journal:  Eur Heart J       Date:  2008-03-27       Impact factor: 29.983

6.  Leaving relativity behind: quantitative clinical perfusion imaging.

Authors:  Frank M Bengel
Journal:  J Am Coll Cardiol       Date:  2011-08-09       Impact factor: 24.094

7.  Healing and adverse remodelling after acute myocardial infarction: role of the cellular immune response.

Authors:  Anja M van der Laan; Matthias Nahrendorf; Jan J Piek
Journal:  Heart       Date:  2012-09       Impact factor: 5.994

Review 8.  Diagnostic accuracy of cardiac positron emission tomography versus single photon emission computed tomography for coronary artery disease: a bivariate meta-analysis.

Authors:  Matthew W Parker; Aline Iskandar; Brendan Limone; Andrew Perugini; Hyejin Kim; Charles Jones; Brian Calamari; Craig I Coleman; Gary V Heller
Journal:  Circ Cardiovasc Imaging       Date:  2012-10-10       Impact factor: 7.792

9.  Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data.

Authors:  Axel Martinez-Möller; Michael Souvatzoglou; Gaspar Delso; Ralph A Bundschuh; Christophe Chefd'hotel; Sibylle I Ziegler; Nassir Navab; Markus Schwaiger; Stephan G Nekolla
Journal:  J Nucl Med       Date:  2009-03-16       Impact factor: 10.057

10.  Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging.

Authors:  R S Beanlands; P J Hendry; R G Masters; R A deKemp; K Woodend; T D Ruddy
Journal:  Circulation       Date:  1998-11-10       Impact factor: 29.690

View more
  2 in total

Review 1.  Clinical use of cardiac PET/MRI: current state-of-the-art and potential future applications.

Authors:  Patrick Krumm; Stefanie Mangold; Sergios Gatidis; Konstantin Nikolaou; Felix Nensa; Fabian Bamberg; Christian la Fougère
Journal:  Jpn J Radiol       Date:  2018-03-10       Impact factor: 2.374

Review 2.  Mitochondrial-Targeted Molecular Imaging in Cardiac Disease.

Authors:  Jinhui Li; Jing Lu; You Zhou
Journal:  Biomed Res Int       Date:  2017-05-30       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.